Trial Profile
A phase II trial of KAR 5585 in patients with pulmonary arterial hypertension
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Rodatristat ethyl (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Karos Pharmaceuticals
- 28 Apr 2016 New trial record